Amvuttra Dosage
Generic name: VUTRISIRAN SODIUM 25mg in 0.5mL
Dosage form: injection
Drug class: Miscellaneous metabolic agents
Medically reviewed by Drugs.com. Last updated on Mar 25, 2025.
Recommended Dosage
The recommended dosage of AMVUTTRA is 25 mg administered by subcutaneous injection once every 3 months.
Administration Instructions
AMVUTTRA is for subcutaneous use only and should be administered by a healthcare professional.
Preparation and Administration
|
|
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
More about Amvuttra (vutrisiran)
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Vyndamax
Vyndamax may be given to reduce death or hospitalization caused by heart problems in adults with ...
Vyndaqel
Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer that may be given to reduce death or ...
Wainua
Wainua (eplontersen) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Tegsedi
Tegsedi (inotersen) is an RNA-targeting treatment that may be used to reduce the symptoms of ...
Onpattro
Onpattro is used to treat polyneuropathy in adults with hereditary transthyretin-mediated ...
Eplontersen
Eplontersen (Wainua) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Patisiran
Patisiran (brand name Onpattro) is an injectable treatment for polyneuropathy caused by hereditary ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.